ArticleBMC veterinary research2024

Treatment with oclacitinib, a Janus kinase inhibitor, down-regulates and up-regulates CD25 and Foxp3 expression, respectively, in peripheral blood T cells of dogs with atopic dermatitis.

Agnieszka Jasiecka-Mikołajczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.